Browse > Article
http://dx.doi.org/10.12750/JET.2016.31.1.97

The Need for the Development of Pig Brain Tumor Disease Model using Genetic Engineering Techniques  

Hwang, Seon-Ung (Laboratory of Veterinary Embryology and Biotechnology, College of Veterinary Medicine, Chungbuk National University)
Hyun, Sang-Hwan (Laboratory of Veterinary Embryology and Biotechnology, College of Veterinary Medicine, Chungbuk National University)
Publication Information
Journal of Embryo Transfer / v.31, no.1, 2016 , pp. 97-107 More about this Journal
Abstract
Although many diseases could be treated by the development of modern medicine, there are some incurable diseases including brain cancer, Alzheimer disease, etc. To study human brain cancer, various animal models were reported. Among these animal models, mouse models are valuable tools for understanding brain cancer characteristics. In spite of many mouse brain cancer models, it has been difficult to find a new target molecule for the treatment of brain cancer. One of the reasons is absence of large animal model which makes conducting preclinical trials. In this article, we review a recent study of molecular characteristics of human brain cancer, their genetic mutation and comparative analysis of the mouse brain cancer model. Finally, we suggest the need for development of large animal models using somatic cell nuclear transfer in translational research.
Keywords
porcine; SCNT; disease-model animal; brain tumor;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J, Gutmann DH, Squire JA, Nagy A and Guha A. 2001. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res. 61:3826-3836.
2 Ding H, Shannon P, Lau N, Wu X, Roncari L, Baldwin RL, Takebayashi H, Nagy A, Gutmann DH and Guha A. 2003. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res. 63:1106-1113.
3 Farin CE, Barnwell CV and Farmer WT. 2015. Abnormal Offspring Syndrome. Bovine Reproduction 620-638.
4 Federspiel MJ, Bates P, Young J, Varmus HE and Hughes SH. 1994. A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proceedings of the National Academy of Sciences 91:11241-11245.   DOI
5 Ghim TT. 2002. Childhood brain tumors. Korean J. Pediatr. 45:1055-1058.
6 Ramirez P, Montoya M, Rios A, Palenciano CG, Majado M, Chavez R, Munoz A, Fernandez O, Sanchez A and Segura B. 2005. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant Proc. 37:4103-6.   DOI
7 Reilly KM, Loisel DA, Bronson RT, McLaughlin ME and Jacks T. 2000. Nf1; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat. Genet. 26:109-113.   DOI
8 Gilbertson RJ. 2004. Medulloblastoma: Signalling a change in treatment. The lancet. Oncology 5:209-218.
9 Guha A, Feldkamp MM, Lau N, Boss G and Pawson A. 1997. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15:2755-2765.   DOI
10 Hambardzumyan D, Amankulor NM, Helmy KY, Becher OJ and Holland EC. 2009. Modeling adult gliomas using RCAS/t-va technology. Translational Oncology 2:89-IN86.   DOI
11 Rideout WM, Eggan K and Jaenisch R. 2001. Nuclear cloning and epigenetic reprogramming of the genome. Science 293: 1093-1098.   DOI
12 Ringertz N. 1950. Grading of gliomas. Acta. Pathol. Microbiol. Scand. 27:51-64.
13 Schuurman H-J and Pierson R. 2008. Progress towards clinical xenotransplantation. Front Biosci. 13:204-220.   DOI
14 Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA and Holland EC. 2004. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res. 64:4783-4789.   DOI
15 Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C and Bogdahn U. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352:987-996.   DOI
16 Suzuki S, Iwamoto M, Saito Y, Fuchimoto D, Sembon S, Suzuki M, Mikawa S, Hashimoto M, Aoki Y and Najima Y. 2012. Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 10:753-758.   DOI
17 Talmadge JE, Singh RK, Fidler IJ and Raz A. 2007. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am. J. Pathol. 170:793-804.   DOI
18 Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A and Louis DN. 1996. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res. 56:150-153.
19 Hitoshi Y, Harris BT, Liu H, Popko B and Israel MA. 2008. Spinal glioma: Platelet-derived growth factor B-mediated oncogenesis in the spinal cord. Cancer Res. 68:8507-8515.   DOI
20 Hara H, Ezzelarab M, Rood PP, Lin YJ, Busch J, Ibrahim Z, Zhu X, Ball S, Ayares D and Zeevi A. 2006. Allosensitized humans are at no greater risk of humoral rejection of GT KO pig organs than other humans. Xenotransplantation 13:357-365.   DOI
21 Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE and Fuller GN. 2000. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25:55-57.   DOI
22 Hoshino Y, Uchida M, Shimatsu Y, Miyake M, Nagao Y, Minami N, Yamada M and Imai H. 2005. Developmental competence of somatic cell nuclear transfer embryos reconstructed from oocytes matured in vitro with follicle shells in miniature pig. Cloning Stem Cells 7:17-26.   DOI
23 Howells DW, Porritt MJ, Rewell SS, O'Collins V, Sena ES, van der Worp HB, Traystman RJ and Macleod MR. 2010. Different strokes for different folks: The rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow. Metab. 30:1412-1431.   DOI
24 Walker SC, Shin T, Zaunbrecher GM, Romano JE, Johnson GA, Bazer FW and Piedrahita JA. 2002. A highly efficient method for porcine cloning by nuclear transfer using in vitro-matured oocytes. Cloning & Stem Cells 4:105-112.   DOI
25 Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M and Holland EC. 2005. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7:356-368.   DOI
26 Betthauser J, Forsberg E, Augenstein M, Childs L, Eilertsen K, Enos J, Forsythe T, Golueke P, Jurgella G and Koppang R. 2000. Production of cloned pigs from in vitro systems. Nat. Biotechnol. 18:1055-1059.   DOI
27 Charest A, Wilker EW, McLaughlin ME, Lane K, Gowda R, Coven S, McMahon K, Kovach S, Feng Y and Yaffe MB. 2006. ROS fusion tyrosine kinase activates a SH2 domaincontaining phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Cancer Res. 66:7473-7481.   DOI
28 Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN and Holland EC. 2002. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res. 62:5551-5558.
29 Uhrbom L, Hesselager G, Nister M and Westermark B. 1998. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 58:5275-5279.
30 Coleman A. 1999. Somatic cell nuclear transfer in mammals: Progress and application. Cloning 1:185-200.   DOI
31 Cushing H and Bailey P. 1926. Classification of tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. Can. Med. Assoc. J. 16:872.
32 Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN and Holland EC. 2001. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes. Dev. 15:1913-1925.   DOI
33 Danks RA, Orian JM, Gonzales MF, Tan S-S, Alexander B, Mikoshiba K and Kaye AH. 1995. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter. Cancer. Res. 55:4302-4310.
34 Wen PY and Kesari S. 2008. Malignant gliomas in adults. N. Engl. J. Med. 359: 492-507.   DOI
35 Wee B, Charles N, and Holland EC. 2011. Animal models to study cancer-initiating cells from glioblastoma. Front Biosci. (Landmark Ed). 16:2243-2258.   DOI
36 Wei Q, Clarke L, Scheidenhelm DK, Qian B, Tong A, Sabha N, Karim Z, Bock NA, Reti R and Swoboda R. 2006. High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. Cancer Res. 66:7429-7437.   DOI
37 Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, Kuriyama H, Kuriyama N, Milshteyn N, Roberts T and Wendland MF. 2003. Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res. 63:1589-1595.
38 Whitworth KM and Prather RS. 2010. Somatic cell nuclear transfer efficiency: How can it be improved through nuclear remodeling and reprogramming? Mol. Reprod. Dev. 77:1001-1015.   DOI
39 Xiao A, Wu H, Pandolfi PP, Louis DN and Van Dyke T. 2002. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1:157-168.   DOI
40 Huse JT and Holland EC. 2010. Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 10:319-331.   DOI
41 Huszthy PC, Daphu I, Niclou SP, Stieber D, Nigro JM, Sakariassen PO, Miletic H, Thorsen F and Bjerkvig R. 2012. In vivo models of primary brain tumors: Pitfalls and perspectives. Neuro-oncol. 14:979-993.   DOI
42 Jaenisch R and Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567-582.   DOI
43 Jeon H-M, Jin X, Lee J-S, Oh S-Y, Sohn Y-W, Park H-J, Joo KM, Park W-Y, Nam D-H and DePinho RA. 2008. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev. 22:2028-2033.   DOI
44 Jin Y-X, Jeon Y, Lee S-H, Kwon M-S, Kim T, Cui X-S, Hyun S-H and Kim N-H. 2014. Production of pigs expressing a transgene under the control of a tetracycline-inducible system. PloS One. 15:e86146.
45 Zhu Z, Zheng T, Lee CG, Homer RJ and Elias JA. 2002b. Tetracycline-controlled transcriptional regulation systems: Advances and application in transgenic animal modeling. Semin. Cell Dev. Biol. 13:121-128.   DOI
46 Xiao A, Yin C, Yang C, Di Cristofano A, Pandolfi PP and Van Dyke T. 2005. Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. Cancer Res. 65:5172-5180.   DOI
47 Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S and Riggins GJ. 2009. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360:765-773.   DOI
48 Young LE, Sinclair KD and Wilmut I. 1998. Large offspring syndrome in cattle and sheep. Rev. Reprod. 3:155-163.   DOI
49 Zhu Y, Ghosh P, Charnay P, Burns DK and Parada LF. 2002a. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296:920-922.   DOI
50 Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A and Parada LF. 2005. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8:119-130.   DOI
51 Zulch K. 1979. Histological typing of tumours of the central nervous system. International Histological Classification of Tumours, vol. 21. Geneva. World Health Organization.
52 강영희. 2008. 생명과학대사전. 서울: 아카데미서적.
53 Lim DH. 2012. 소아뇌종양의 치료 원칙. J. Korean Med. Assoc. 55:418-419.   DOI
54 Jung K-W, Won Y-J, Kong H-J, Oh C-M, Cho H, Lee DH and Lee KH. 2015. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2012. Cancer Research and Treatment: Official Journal of Korean Cancer Association 47:127.   DOI
55 Kararli TT. 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 16:351-380.   DOI
56 Kernohan JW and Mabon R. 1949. A simplified classification of the gliomas. Proceedings of the Staff Meetings Mayo Clinic 24:71-75.
57 Kwon C-H, Zhao D, Chen J, Alcantara S, Li Y, Burns DK, Mason RP, Eva Y-HL, Wu H and Parada LF. 2008. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res. 68:3286-3294.   DOI
58 Li X, Zhou X, Guan Y, Wang Y-XJ, Scutt D and Gong Q-Y. 2006. N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model: Radiological and histopathological studies. Cardiovasc Intervent Radiol. 29:420-428.   DOI
59 Llaguno SA, Chen J, Kwon C-H, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A and Parada LF. 2009. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15:45-56.   DOI
60 Longo D, Fauci A, Kasper D and Hauser S. 2011. Harrison's Principles of Internal Medicine 18th edition (McGraw-Hill Professional).
61 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta. Neuropathol. 114:97-109.   DOI
62 Macleod KF and Jacks T. 1999. Insights into cancer from transgenic mouse models. J. Pathol. 187:43-60.   DOI
63 Organization WH. 2014. World Cancer Report, 2014. WHO Report Geneva: WHO.
64 McGregor CG, Davies WR, Oi K, Teotia SS, Schirmer JM, Risdahl JM, Tazelaar HD, Kremers WK, Walker RC and Byrne GW. 2005. Cardiac xenotransplantation: Recent preclinical progress with 3-month median survival. J. Thorac. Cardiovasc. Surg. 130:844, e841-844, e849.
65 McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, Olson JJ, Mikkelsen T, Lehman N and Aldape K. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.   DOI
66 McNeil CJ, Nwagwu MO, Finch AM, Page KR, Thain A, McArdle HJ and Ashworth CJ. 2007. Glucocorticoid exposure and tissue gene expression of $11{\beta}$ HSD-1, $11{\beta}$ HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth. Reproduction 133:653-661.   DOI
67 Ogura A, Inoue K and Wakayama T. 2013. Recent advancements in cloning by somatic cell nuclear transfer. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 368:20110329.
68 Ohgaki H, Kita D, Favereaux A, Huang H, Homma T, Dessen P, Weiss WA, Kleihues P and Heppner FL. 2006. Brain tumors in $S100{\beta}$-v-erbB transgenic rats. J. Neuropathol. Exp. Neurol. 65:1111-1117.   DOI
69 Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS. 2013. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-oncol. 15:ii1-ii56.
70 Park K-W, Cheong H-T, Lai L, Im G-S, Kuhholzer B, Bonk A, Samuel M, Rieke A, Day BN and Murphy CN. 2001. Production of nuclear transfer-derived swine that express the enhanced green fluorescent protein. Anim. Biotechnol. 12:173-181   DOI